Lexology November 11, 2024
In the wake of the biggest American political comeback in more than 100 years, stakeholders in the health industry are asking themselves: What does this portend for health policy—patients, providers, manufacturers, and insurers? This memorandum, prepared before the majority for the U.S. House of Representatives has been determined, provides a high-level overview of the ‘What’ and ‘When’ we can expect in health policy over the coming months and next two years.
Trump Administration likely actions
Deep FDA Reform. Trump is not your average Republican on pharmaceutical and food oversight issues. ‘MAHA,’ or Make America Healthy Again, became a staple of the Trump campaign message and his advisors, including Robert F. Kennedy, Jr., promised the American people that a Trump White...
Today's Sponsors
Today's Sponsor